Products

Bovine Delphinium virus cDNA and Antigen

Cat#

Product Name

Swiss Prot#

Size

Price (US$)

Order

PN0086

Recombinant Protein-BDV Glycoprotein (a.a.28 to 503)

A4D830

100 µg

1195

Order

PN0087

Recombinant Protein-BDV P40 (a.a.19 to 146)

O10407

100 µg

1195

Order

PN0088

Recombinant Protein-BDV N protein (a.a.21 to 370)

Q5GL86

100 µg

1195

Order

PN0089

Recombinant Protein-BDV P24 (a.a.21 to 202)

Q64GK8

100 µg

1195

Order

PN0090

Recombinant Protein-BDV P16 protein (a.a.21 to 142)

Q65455

100 µg

1195

Order

PN0091

Recombinant Protein-BDV X protein-P10 protein (a.a.1 to 87)

Q9WNA1

100 µg

1195

Order

RPN0086

 cDNA-BDV Glycoprotein (a.a.28 to 503)

A4D830

2 µg

2375

Order

RPN0087

 cDNA-BDV P40 (a.a.19 to 146)

O10407

2 µg

700

Order

RPN0088

 cDNA-BDV N protein (a.a.21 to 370)

Q5GL86

2 µg

1745

Order

RPN0089

 cDNA-BDV P24 (a.a.21 to 202)

Q64GK8

2 µg

905

Order

RPN0090

 cDNA-BDV P16 protein (a.a.21 to 142)

Q65455

2 µg

700

Order

RPN0091

 cDNA-BDV X protein-P10 protein (a.a.1 to 87)

Q9WNA1

2 µg

700

Order

Bovine Delphinium virus cDNA and recombinant antigen

  • Codon-optimized cDNA is cloned into E. coli expression vector with 6x His-tag at N-terminus and ready-to-use for recombinant protein production.
  • Recombinant protein applications: Western Blot may be used for other applications determined by the user.
  • Protein Purity: >90%, as determined by SDS-PAGE under reducing conditions.
  • Protein Activity: N/A
  • Protein Tag:  Contains A 6x histidine tag at N-terminus.
  • Protein Formulation: Liquid
  • Source: Produced from E. coli

Bovine Delphinium virus (BDV) is a pathogenic virus that can cause a viral disease in cattle. BDV is a member of the Nodaviridae family and causes symptoms such as fever, weight loss, and decreased milk production. BDV infections can have a significant economic impact on the livestock industry, leading to decreased weight gain, decreased milk production, and decreased fertility. It is important to take preventive measures such as vaccination and biosecurity measures to control BDV infections in cattle populations.

Bovine Delphinium virus (BDV) antigen refers to a substance that is recognized by the immune system as foreign and triggers the production of antibodies. This antigen is found in the BDV virus and can be used in laboratory tests to detect BDV infections in cattle. Detection of BDV antigen in blood or serum samples can help diagnose BDV infections and monitor the effectiveness of vaccines against the virus.

The genome of Bovine Delphinium virus (BDV) is the complete genetic material of the virus. It is composed of a single-stranded RNA (ribonucleic acid) molecule and is approximately 4 kilobases in length. The BDV genome encodes for several proteins that are involved in virus replication, assembly, and pathogenesis. Understanding the BDV genome can help in the development of diagnostic tools and vaccines for the control of BDV infections in cattle. The genome can also be used to study the genetic diversity and evolution of BDV in different cattle populations.

Glycoprotein: This protein is a surface protein that is involved in viral attachment and entry into host cells.

P40: This protein is a non-structural protein that is involved in viral replication and transcription.

N protein: This protein is a structural protein that is involved in encapsidation of the viral RNA genome.

P24: This protein is a non-structural protein that is involved in viral replication and transcription.

P16: This protein is a non-structural protein that is involved in viral replication and transcription.

P10: This protein is a non-structural protein that is involved in viral replication and transcription.

The recombinant antigen can be used in an ELISA or competitive ELISA to detect antibodies to BDV in cattle serum samples. This allows for the rapid diagnosis of BDV infection and helps to identify infected animals in herds. The recombinant antigen can also be used in a vaccine to protect cattle from BDV infection. The vaccine is made up of the recombinant antigen and an adjuvant and has been shown to provide protection against BDV infection in cattle.

The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E. coli expression Vector), which are ready for production of the recombinant proteins.

 

Welcome to BitClone

Magnetic Beads Make Things Simple